BioCRF Seminar



High content analysis for cell imaging analysis and

drug discovery

Dr. Dong Wang

Product Marketing Manager

GE Healthcare Life Sciences

Date:       24 January 2011 (Monday)

Time:      3:30 - 4:30 pm

Venue:    Room 5510, Lift No. 25-26



After completion of the sequencing of the human genome we are now entering the postgenomic age. The main focus in genomic research is switching from sequencing to using the genome sequences in order to understand how genomes are functioning.

Although we tend to take our current technologies for granted, sometimes it’s helpful to take a step back and appreciate that over the past decade or so we’ve experienced an enormous revolution in the way we do science.  No longer are we confined to looking at genes one at a time in isolation, instead a wave of new advances in sequencing and microarray technologies have enabled us to investigate nucleic acids on a genome-wide scale.  The same is true with proteins—we now have robust technologies to examine entire proteomes en masse.  The latest advance is to extend this concept to the cell level, where we can examine the function and behaviour of genes and proteins in a more physiologically relevant context.  The leading technology that has made this possible is called “high content analysis”.

High content analysis technology has being used in cell imaging analysis, neurons studies, and drug discovery research, with which powerful tools, we will accelerate our process to success.  

All Are Welcome

Co-organized with GE Healthcare


© 2018  BioCRF - The Hong Kong University of Science and Technology.  Policy Statements